Comparison of Chemoembolization Outcomes Using 70-150 μm and 100-300 μm Drug-Eluting Beads in Treating Small Hepatocellular Carcinoma: A Korean Multicenter Study

  • Lee, Byung Chan; 
  • Kim, Gyoung Min; 
  • Park, Juil; 
  • Chung, Jin Wook; 
  • Choi, Jin Woo; 
  • 외 4명
Citations

WEB OF SCIENCE

4
Citations

SCOPUS

4

초록

Objective: To evaluate the outcomes of drug-eluting bead transarterial chemoembolization (DEB-TACE) according to the size of the beads for the treatment of small hepatocellular carcinoma (HCC). Materials and Methods: This retrospective study included 212 patients with a single HCC <= 5 cm from five tertiary institutions. One hundred and nine patients were treated with 70-150-mu m doxorubicin DEBs (group A), and 103 patients received 100-300-mu m doxorubicin DEBs (group B). The initial tumor response (assessed between 3 weeks and 2 months after DEB-TACE), time to local tumor progression (TTLTP), restricted mean duration of complete response (RMDCR), rate of complications, incidence of post-embolization syndrome, and length of hospital stay were compared between the two groups. Logistic regression was used to analyze prognostic factors for initial tumor response. Results: The initial objective response rates were 91.7% (100/109) and 84.5% (87/103) for groups A and B, respectively (P = 0.101). In the subgroup analysis of tumors <= 3 cm, the initial objective response rates were 94.6% (53/56) and 78.0% (39/50) for groups A and B, respectively (P = 0.012). There was no significant difference in the TTLTP (median, 23.7 months for group A vs. 19.0 months for group B; P = 0.278 [log-rank], 0.190 [multivariable Cox regression]) or RMDCR at 24 months (11.4 months vs. 8.5 months, respectively; P = 0.088). In the subgroup analysis of tumors >3-cm, the RMDCR at 24 months was significantly longer in group A than in group B (11.8 months vs. 5.7 months, P = 0.024). The incidence of mild bile duct dilatation after DEB-TACE was significantly higher in group B than in group A (5.5% [6/109] vs. 18.4% [19/103], P = 0.003). Conclusion: DEB-TACE using 70-150-mu m microspheres demonstrated a higher initial objective response rate in <= 3-cm HCCs and a longer RMDCR at 24 months in 3.1-5-cm HCCs compared to larger DEBs (100-300-mu m).

키워드

Chemoembolization; Drug-eluting bead; Hepatocellular carcinoma; TRANSARTERIAL CHEMOEMBOLIZATION; MODIFIED RECIST; TUMOR RESPONSE; EFFICACY; SAFETY; PARTICLES; ONCOLOGY; SURVIVAL
제목
Comparison of Chemoembolization Outcomes Using 70-150 μm and 100-300 μm Drug-Eluting Beads in Treating Small Hepatocellular Carcinoma: A Korean Multicenter Study
저자
Lee, Byung Chan; Kim, Gyoung Min; Park, Juil; Chung, Jin Wook; Choi, Jin Woo; Chun, Ho Jong; Oh, Jung Suk; Hyun, Dong Ho; Yang, Jung Ho
DOI
10.3348/kjr.2024.0231
발행일
2024-08
유형
Article
저널명
Korean Journal of Radiology
권
25
호
8
페이지
715 ~ 725